Discover 921 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 921
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Portland OR, Newberg OR, Oregon City OR, Seattle WA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 65+
Code: NCT07321652
Phase3, Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
for
Coronary Arterial Disease (CAD),
Location: Portland OR, Bellevue WA, San Francisco CA, Stanford CA,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT06959524
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
for
Pancreatic Neoplasm
Location: Portland OR, Newberg OR, Vancouver WA, Clackamas OR,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 50 - 70+
Code: NCT04239573
Recruiting
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
for
AMI Cardiogenic Shock
Location: Portland OR, Torrance CA, Orange CA, Albuquerque NM,
Sponsor: Abiomed Inc.
Sex: All
Age: 18+
Code: NCT06964685
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
E-Mindfulness Approaches for Living After Breast Cancer
for
Breast Cancer, Depression
Location: Portland OR, Newberg OR, Oregon City OR, Salem OR,
Sponsor: NRG Oncology
Sex: All
Age: 18 - 50
Code: NCT06748222
Phase3, Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
for
Prostate Cancer (Adenocarcinoma)
Location: Portland OR, Newberg OR, Vancouver WA, Clackamas OR,
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06592924
Phase3, Recruiting
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
for
High Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements,
Location: Portland OR, Seattle WA, Post Falls ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06649812
Phase2, Recruiting
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Portland OR, Olympia WA, Seattle WA, Edmonds WA,
Sponsor: Swedish Medical Center
Sex: All
Age: 18+
Code: NCT07108660
Recruiting
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
for
Castration-Resistant Prostate Carcinoma,
Location: Portland OR, Seattle WA, Edmonds WA, Chico CA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06632977
Phase2, Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Portland OR, Newberg OR, Oregon City OR, Lacey WA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase2, Recruiting
Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients
for
Triple Negative Breast Cancer
Location: Portland OR, Los Angeles CA
Sponsor: Providence Health & Services
Sex: All
Age: 18+
Code: NCT06353997
Phase2, Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
for
Hodgkin Lymphoma, Non-Hodgkin Lymphoma
Location: Portland OR, Newberg OR, Vancouver WA, Clackamas OR,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06002828
Recruiting
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for
Biochemically Recurrent Prostate Carcinoma,
Location: Portland OR, Newberg OR, Vancouver WA, Clackamas OR,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male
Age: 18+
Code: NCT04423211
Phase3, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
for
Colorectal Neoplasms
Location: Portland OR, Tigard OR, Newberg OR, Happy Valley OR,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05253651
Phase3, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Portland OR, Vancouver WA, Seattle WA, Edmonds WA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase3, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Portland OR, Newberg OR, Oregon City OR, Issaquah WA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase2, Recruiting
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
for
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8,
Location: Portland OR, Newberg OR, Vancouver WA, Clackamas OR,